Archives

by in
Entry Author Date Location
Omeros Pockets $28M in Stock Sale 06/28/12 Seattle
Omeros Bounces Back With Drug For Eye Surgeries; Shares Climb 03/13/12 Seattle
The Thinking Behind Domain’s $760M Life Sciences Deal in Russia 03/07/12 San Diego
Regeneron Wins FDA Approval of Drug for Leading Cause of Blindness in Elderly 11/18/11 New York
InSite, Merck Sue Sandoz Over Patent 05/26/11 San Francisco
Acucela Adds Finance Chief 04/26/11 Seattle
Merck Buys Inspire for $430M 04/05/11 New York
Genentech Eye Drug, Under Scrutiny, Passes Study in Diabetic Patients to Open Up New Market 03/25/11 San Francisco
Omeros Combo Drug Passes Cataract Surgery Study 03/23/11 Seattle
Page 1 of 1